Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Condition: Community-acquired Bacterial PneumoniaInterventions: Drug: Solithromycin; Drug: MoxifloxacinSponsor: Cempra PharmaceuticalsCompleted - verified October 2014

http://clinicaltrials.gov/ct2/show/NCT01756339?lup_s=10%2F01%2F2014&lup_d=30

Source: ClinicalTrials.gov - December 24, 2012 Category: Research Source Type: clinical trials